Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
Scientific Reports|May 14, 2020
Effects of synchronised engine sound and vibration presentation on visually induced motion sicknessYuki Sawada, Yoshihiro Itaguchi, Masami Hayashi, et al.Oncotargets and Therapy|April 21, 2020
The Protective Effect of Testosterone on the Ovarian Reserve During Cyclophosphamide TreatmentMasae Yoo, Tomohito Tanaka, Hiromi Konishi, et al.Journal of Biochemistry|April 6, 2005
Involvement of calpain in osteoclastic bone resorptionMasami Hayashi, Yasuko Koshihara, Hideaki Ishibashi, et al.The Journal of Endocrinology|September 24, 2014
Decorin induced by progesterone plays a crucial role in suppressing endometriosisYoshihiro Joshua Ono, Yoshito Terai, Akiko Tanabe, et al.Reproductive Medicine and Biology|December 21, 2017
The effect of moderate to severe endometriosis on expression of growth differentiation factor-9 mRNA in human granulosa cells under controlled ovarian hyperstimulationSachiko Kawabe, Yoshiki Yamashita, Natsuho Saito, et al.Anaerobe|May 17, 2006
Perfringolysin O, a cholesterol-binding cytolysin, as a probe for lipid raftsYoshiko Ohno-Iwashita, Yukiko Shimada, A Abdul Waheed, et al.Placenta|June 18, 2018
Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsiaTakumi Sano, Yoshito Terai, Atsushi Daimon, et al.The Journal of Clinical Endocrinology and Metabolism|December 16, 2004
Hypoxia up-regulates hypoxia-inducible factor-1alpha expression through RhoA activation in trophoblast cellsMasami Hayashi, Masahiro Sakata, Takashi Takeda, et al.Oncology Letters|March 21, 2020
Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancerKeisuke Ashihara, Yoshito Terai, Tomohito Tanaka, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2011
The activity of trabectedin as a single agent or in combination with everolimus for clear cell carcinoma of the ovarySeiji Mabuchi, Takeshi Hisamatsu, Chiaki Kawase, et al.Pageof 7